Betahistine Mesilate

Purui’s Product Introduction Betahistine Mesilate (CAS 54856-23-4) is a pharmaceutical-grade vestibular modulator and vasodilator, strictly compliant with USP and EP standards. It selectively improves blood circulation in the inner ear, regulates vestibular function, and effectively alleviates symptoms such as vertigo, tinnitus, and hearing loss caused by inner ear disorders. As a trusted supplier, we offer Bulk Betahistine Mesilate supply and Betahistine Mesilate for Sale services, catering to pharmaceutical manufacturers, prescription drug brands, and medical research institutions globally. Our mature production and inventory management system ensures stable supply, supporting both large-scale production and urgent procurement needs.

Product Parameters (Specification)

Product Features and Applications

Dual-pharmacopoeia compatibility: Complies with both USP and EP standards, enabling finished products to enter global mainstream pharmaceutical markets without regulatory barriers;

Targeted efficacy: Specifically acts on the inner ear microcirculation, with strong selectivity and rapid onset of action, addressing the root cause of vestibular disorders;

High safety profile: Low incidence of adverse reactions, well-tolerated by both adults and elderly patients, suitable for long-term clinical application;

Strong formulation adaptability: Compatible with common excipients, supporting the development of oral dosage forms such as tablets, capsules, and oral solutions.

Application Scenarios:Widely used as a core raw material for prescription and OTC medications, mainly indicated for:

Meniere’s syndrome (relieving vertigo, tinnitus, ear fullness, and progressive hearing loss);

Vestibular vertigo caused by inner ear ischemia, vestibular neuritis, or post-infection sequelae;

Cerebrovascular insufficiency-induced dizziness and balance disorders.It is a first-line choice for vestibular disorder treatment in global clinical practice, with high market recognition.

Procurement and Service Support

As your dedicated Betahistine Mesilate Exporter, we provide all-round procurement solutions:

Bulk Betahistine Mesilate supply: Flexible pricing policies based on order volume, with preferential terms for long-term strategic partnerships;

Global distribution capacity: Professional logistics planning, including cold-chain transportation if required, ensuring timely and safe delivery to overseas destinations;

Comprehensive documentation support: Provide full sets of quality inspection reports (USP/EP compliant), certificate of analysis, and customs clearance documents to meet regulatory requirements in different countries;

Responsive order fulfillment: Betahistine Mesilate for Sale with sufficient inventory, supporting quick shipment for urgent orders and customized packaging upon request.

FAQ

Q1：What are the main clinical indications of Betahistine Mesilate?

A1：It is mainly used to treat vertigo, tinnitus and hearing loss caused by Meniere's disease, vestibular dysfunction and inner ear circulation disorders.

Q2：What therapeutic effect does Betahistine Mesilate exert on the inner ear?

A2：It improves microcirculation and relieves capillary spasm in the inner ear, effectively reducing vestibular dizziness and alleviating recurrent vertigo symptoms.

Q3：In which long-term adjuvant treatment scenarios is Betahistine Mesilate commonly used?

A3：It is widely used for daily maintenance treatment of chronic vestibular vertigo, post-cerebral infarction dizziness and cervical vertigo adjuvant therapy.